Making the case for pediatric research: a life-cycle approach and the return on investment

Daniel P Gitterman1, William W Hay2, W Scott Langford3

  • 1Public Policy, University of North Carolina, CB #3435, Chapel Hill, NC, 27599-3435, USA. danielg@email.unc.edu.

Pediatric Research
|July 11, 2022
PubMed

Insights

Increased funding for pediatric and perinatal research is evident, yet a life-cycle approach is crucial. Researchers must demonstrate long-term health benefits from early life interventions to inform public policy.

Area of Science:

  • Pediatric Research
  • Perinatal Health
  • Developmental Origins of Health and Disease

Background:

  • National Institutes of Health (NIH) funding for pediatric and perinatal research has increased.
  • Significant work remains to optimize the impact of this research.
  • Current research often lacks a long-term, life-cycle perspective.

Purpose of the Study:

  • To advocate for a life-cycle approach to maximize the return on investment in pediatric and perinatal research.
  • To emphasize the need for evidence demonstrating long-term health benefits of early life interventions.
  • To improve communication of early developmental impacts on adult disease to the public and policymakers.

Main Methods:

  • This study is a perspective piece advocating for a research funding and communication strategy.
  • It synthesizes existing knowledge on the importance of early life events.
  • It proposes a framework for demonstrating long-term health outcomes.

Main Results:

  • Increased NIH funding for pediatric and perinatal research is acknowledged.
  • A life-cycle approach is proposed to sustain research benefits.
  • The necessity of demonstrating long-term health impacts is highlighted.

Conclusions:

  • A life-cycle perspective is essential for pediatric and perinatal research to demonstrate lifelong health benefits.
  • Researchers must bridge the gap between short-term policy horizons and long-term health outcomes.
  • Effective communication is vital to underscore the importance of early development for public health and policy.

Related Concept Videos

Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
169
Longitudinal Studies01:26

Longitudinal Studies

Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
228
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.3K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
7.2K